Re-examine the transfusion transmitted risk of SARS-CoV-2 virus during a major COVID-19 outbreak in 2022
- PMID: 37286528
- DOI: 10.1111/tme.12981
Re-examine the transfusion transmitted risk of SARS-CoV-2 virus during a major COVID-19 outbreak in 2022
Abstract
Introduction: Although no case of COVID-19 transmission through transfusion has been reported, blood transfusion service (BTS) continues to implement pre-donation and post-donation measures to minimise the risk. In year 2022, when local healthcare system was badly impacted by a major outbreak, it opened an opportunity to re-examine the viraemia risk in these asymptomatic donors.
Materials and methods: Records were retrieved from blood donors who reported COVID-19 after donation and follow-up was also made for recipients who received their blood. Blood samples at donation were tested for SARS-CoV-2 viraemia by single-tube nested real-time RT-PCR assay designed to detect most SARS-CoV-2 variants including the prevailing delta and omicron variants.
Results: From 1 January to 15 August 2022, the city with 7.4 M inhabitants recorded 1 187 844 COVID-19 positive cases and 125 936 successful blood donations were received. 781 donors reported to the BTS after donation with 701 being COVID-19 related (including close contact and symptoms respiratory tract infection). 525 COVID-19 were positive at the time of call back or follow-up. Of the 701 donations, they were processed into 1480 components with 1073 discarded upon donors' call back. For remaining 407 components, no recipient was found to have adverse event or COVID-19 positive. 510 samples from the above 525 COVID-19 positive donors were available and all tested negative for SARS-CoV-2 RNA.
Discussion: With the negative SARS-CoV-2 RNA in blood donation samples and follow up data in transfusion recipients, the risk of transfusion transmitted COVID-19 appears negligible. However, current measures remains important in securing blood safety with ongoing surveillance of their effectiveness.
Keywords: COVID-19; SARS-CoV-2; blood donation; blood donor; delta variant; omicron variant; risk; transfusion transmitted infection.
© 2023 British Blood Transfusion Society.
References
REFERENCES
-
- Leung JNS, Lee C-K. Impact of the COVID-19-a regional blood centre's perspective. ISBT Sci Ser. 2020;15:362-364.
-
- Luzzi JR, Navarro R, Dinardo CL. COVID-19: further evidence of no transfusion transmission. Transfus Apher Sci. 2021;60:102961.
-
- Noordin SS, Yusoff NM, Karim FA, Chong SE. Blood transfusion services amidst the COVID-19 pandemic. J Glob Health. 2021;11:03053.
-
- Shander A, Goobie SM, Warner MA, et al. Essential role of patient blood management in a pandemic: a call for action. Anesth Analg. 2020;131:74-85.
-
- Stanworth SJ, New HV, Apelseth TO, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7:e756-e764.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
